As of a few days ago, the NIH’s recommendation for Ivermectin is the same as for any of the monoclonal antibodies that cause no controversy whatsoever.
The problem with ivermectin is the same as for HCQ: no private group is going to fund a large expensive RCT, so the only option is to have a government funded study. There is no legitimate reason that the NIH hasn’t done this. Very strange. I’m sure there’s a perfectly innocent explanation though.
There are myriad studies already on Ivermectin.